SavedAdd your journal

Journals / Turkish Journal of Cancer / 2001 / Cilt: 31 - Sayı: 2

Stereologic estimation of mean nuclear volume in invasive ductal carcinoma of the breast: İt's impact on prognosis

Gülsüm Özlem ELPEK
Şeyda KARAVELİ
Mehmet Ali ÖZGÜR
Osman SAKA
Pages
47–56
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results of our study indicate that estimation of mean nuclear volume could be an easy, fast, and objective method to predict the survival in patients with invasive ductal carcinoma of the breast and might be used as a supplement to conventional prognostic parameters.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The objective et ve of this study is to evaluate the prognostic value of Stereologic estimation of mean nuclear volume in patients with invasive ductal carcinoma of the breast.
📊
Key Findings & Data:Stereologic method of point-sampled intercepts was performed to estimate mean nuclear volume by using an orientation frame and a test system in routinely processed tissue sections. in statistical analysis mean nuclear volume was significantly higher in tumors with larger tumour size, lymph node involvement and advanced stage.
💡
Conclusion & Impact:Results of our study indicate that estimation of mean nuclear volume could be an easy, fast, and objective method to predict the survival in patients with invasive ductal carcinoma of the breast and might be used as a supplement to conventional prognostic parameters.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Meme neoplazmları · Seyir · Çok değişkenli analiz

Abstract

The objective et ve of this study is to evaluate the prognostic value of Stereologic estimation of mean nuclear volume in patients with invasive ductal carcinoma of the breast. Sixty-nine patients were included in our study group. Stereologic method of point-sampled intercepts was performed to estimate mean nuclear volume by using an orientation frame and a test system in routinely processed tissue sections. in statistical analysis mean nuclear volume was significantly higher in tumors with larger tumour size, lymph node involvement and advanced stage. The prognosis of patients with high mean nuclear volume was found to be worse than cases with low mean nuclear volume. Multivariate analysis revealed that mean nuclear volume was an independent prognostic factor. Results of our study indicate that estimation of mean nuclear volume could be an easy, fast, and objective method to predict the survival in patients with invasive ductal carcinoma of the breast and might be used as a supplement to conventional prognostic parameters.

Özet

Stereologic estimation of mean nuclear volume in invasive ductal carcinoma of the breast: İt's impact on prognosis

🔖

Cite This Article

ELPEK, G. Ö., KARAVELİ, Ş., ÖZGÜR, M. A., SAKA, O. (2001). Stereologic estimation of mean nuclear volume in invasive ductal carcinoma of the breast: İt's impact on prognosis. Turkish Journal of Cancer, Cilt: 31 - Sayı: 2, 47–56. https://ajindex.com/articles/368381

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Landis SH, Taylor M, Bolden S, et al. Cancer statistics,1998. CA Cancer J Clin 1998;48:6-29
  2. Bonadonna G, Valagussa P, Rossi A, et al. Ten years experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985;5:95-115
  3. Bonadonna G, Valagussa P, Rossi A, et al. Adjuvant CMF chemotherapy in operable breast cancer: ten years later. Lancet 1985;2:976-7
  4. Early breast cancer trialists’ collaborative group. Effects of adjuvant tamoxifen and cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28896 women. N Engl J Med 1988;319:1681-92
  5. Isola J, Visakorpi T, Holli K, et al. Association of overexpression of tumor suppressor proteins p53 with rapid proliferation and poor prognosis in nodenegative breast cancer patients. J Natl Cancer Inst 1992;84:1109-14
  6. Toi M, Osaki A, Yamada H, et al. Epidermal growth factor receptor expression as a prognostic indicator in breast cancer. Eur J Cancer 1991;27:977-80
  7. Altomaa S, Lipponen P, Syrjannen K. Nucleolar organiser regions related to morphometry, flow cytometry, sex steroid receptor content, tumour histology and prognosis in female breast cancer. Path Res Pract 1993;189:416-21
  8. Eskelinen M, Lipponen P, Papinaho S, et al. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer. Int J Cancer 1992;51:555-61
  9. Toikkanen S, Joensuu H. Prognostic factors and long term survival in breast cancer in a defined urban population. APMIS 1990;98:1005-14
  10. Baak JPA, van Dop H, Kurver PHJ, et al. The value of morphometry to classic prognosticators in breast cancer. Cancer 1985;56:374-82
  11. Uyterlinde AM, Baak JPA, Schipper NW, et al. Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast cancer patients with long follow-up. Int J Cancer 1990;45:1-7
  12. Laroye GJ, Minkin S. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status. Mod Pathol 1991;4:456-60
  13. Landis SH, Taylor M, Bolden S, et al. Cancer statistics,1998. CA Cancer J Clin 1998;48:6-29
  14. Bonadonna G, Valagussa P, Rossi A, et al. Ten years experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985;5:95-115
  15. Bonadonna G, Valagussa P, Rossi A, et al. Adjuvant CMF chemotherapy in operable b